Cover image of the article: The incidence of complications of vaccination in children and infants of Semnan, Iran

Image Credit:Koomesh

The incidence of complications of vaccination in children and infants of Semnan, Iran

Authors

Mohammad Nabovi, Jafar Jandaghi, Mohammad KhaleghiHashemian,*, Hoda Shojaei, Saba MaherBanaei, Farzaneh MohammadZadeh, Mojtaba GhadamYari, Sanaz Bayat, Mina Dianak Shori Zahrafaraji, Raheb GhorbaniRaheb Ghorbani ORCID
*Corresponding Author: Email: mohammad.hashemian@gmail.com

Koomesh:Vol. 11, issue 4; 245-254
Published online:May 25, 2010
Article type:Research Article
Received:May 25, 2009
Accepted:Mar 14, 2010
How to Cite:Nabovi M, Jandaghi J, KhaleghiHashemian M, Shojaei H, MaherBanaei S, et al. The incidence of complications of vaccination in children and infants of Semnan, Iran. koomesh. 2010;11(4):e152294. doi:

Abstract

  Introduction: Vaccination has achieved significant and cost effective success in prevention of infectious disease. Although the current vaccines used are very effective and their side effects are minimal, generally no vaccine is not free from side effects. Incidence of adverse reactions after immunization may discourage people for further immunization of their children. The aim of this work was to determine the incidence of complications of vaccination in children and infants of Semnan, Iran .   Materials and methods: In a longitudinal study (prospective), all vaccinated children between September 2006 and March 2007 in 11 vaccination centers were studied. A specific questionnaire, including vaccine recipient profile, type of vaccine, birth weight, feeding and 46 adverse reactions were completed immediately after and 2,4,6,12,18 months later .   Results: 5776 children were studied. 29% of the children showed at least one adverse reaction of vaccination. The most common adverse reactions were: fever (24%), pain at injection site (3.8%), swelling (2.5%), erythema (2.5%), induration (2.1%), and ulceration at injection site (2.1%). Incidence of other complications was below 1%. The most dangerous complication of the vaccine was encephalitis (one case) and two cases had febrile seizures. The most cause of hospitalization was adverse reaction of MMR vaccine. Finally, of every four children, one child showed at least one complication that fever was the most common.   Conclusion: In general, routine immunization program of Iran country against nine common infectious diseases has lower complications. This complication is mainly mild and transient and do not need any intervention by drugs. However, among these may be rare and dangerous complications such as seizures and encephalitis occur. Hence, a careful follow-up program is required to report complications of immunization

Highlights

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Oct
2008
Survey of Complications of Triple Vaccine in Yazd in 2005

Survey of Complications of Triple Vaccine in Yazd in 2005

J Ayatollahi,
A Zare,
M Kheirandish

Ayatollahi J, Zare A, Kheirandish M. Survey of Complications of Triple Vaccine in Yazd in 2005. Shiraz E-Med J. 2008;9(4):e93753. doi:

26
Nov
2017
A Survey on Measles and Rubella Supplementary Immunization Activities (SIAs) in Iran

A Survey on Measles and Rubella Supplementary Immunization Activities (SIAs) in Iran

Seyed Mohsen Zahraei,
Mohammad Mehdi Gouya,
Mahdi Mohammadi,
Seyed Mehdi Tabatabaei,
Mehdi Zanganeh,
Iraj Zareban
,et al.

Zahraei SM, Gouya MM, Mohammadi M, Tabatabaei SM, Zanganeh M, et al. A Survey on Measles and Rubella Supplementary Immunization Activities (SIAs) in Iran. Health Scope. 2017;6(4):e64184. doi: https://doi.org/10.5812/jhealthscope.64184

8
Sep
2012
Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination

Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination

Ahmad Shamsizadeh,
Roya Nikfar,
Manoochehr Makvandi,
Makvandi Hakimzadeh,
Mohsen Alisamir,
Tahereh Ziaei

Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, et al. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination. Jundishapur J Microbiol. 2012;5(4):578-581. doi: https://doi.org/10.5812/jjm.4563

11
Aug
2026
Evaluation of Demographic, Clinical, and Paraclinical Profile of Hospitalized Children with Measles

Evaluation of Demographic, Clinical, and Paraclinical Profile of Hospitalized Children with Measles

Gholamreza Soleimani,
Aghil Miri,
Seyed Hosein Soleimanzadeh Mousavi,
Mohamad Nabatzehi,
Saeedeh Yaghoubi

Soleimani G, Miri A, Soleimanzadeh Mousavi SH, Nabatzehi M, Yaghoubi S. Evaluation of Demographic, Clinical, and Paraclinical Profile of Hospitalized Children with Measles. Arch Pediatr Infect Dis. 2026;14(4):e168921. doi: https://doi.org/10.5812/apid-168921

27
Nov
2018
Complications of Bacillus Calmette-Guérin Vaccination at a University Hospital in Iranian Neonates

Complications of Bacillus Calmette-Guérin Vaccination at a University Hospital in Iranian Neonates

Soheila Siroosbakht,
Bijan Rezakhaniha

Siroosbakht S, Rezakhaniha B. Complications of Bacillus Calmette-Guérin Vaccination at a University Hospital in Iranian Neonates. J Compr Ped. 2019;10(1):e67098. doi: https://doi.org/10.5812/compreped.67098

More by these authors

Mohammad NaboviPubMedScholar
Jafar JandaghiPubMedScholar
Mohammad KhaleghiHashemianPubMedScholar
Hoda ShojaeiPubMedScholar
Saba MaherBanaeiPubMedScholar
Farzaneh MohammadZadehPubMedScholar
Mojtaba GhadamYariPubMedScholar
Sanaz BayatPubMedScholar
Mina Dianak Shori ZahrafarajiPubMedScholar
Raheb GhorbaniPubMedScholar
Share
Cited by
Metrics